Target of rapamycin complex 2 regulates cell growth via Myc in drosophila

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kuo, Ying ^a   Huang, Huanwei ^a   Cai, Tao ^a   Wang, Tao ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DROSOPHILA PROTEIN; LST8 PROTEIN, DROSOPHILA; MESSENGER RNA; MULTIPROTEIN COMPLEX; MYC PROTEIN; RICTOR PROTEIN, DROSOPHILA; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANATOMY AND HISTOLOGY; ANIMAL; CELL NUCLEUS; DROSOPHILA; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; LARVA; METABOLISM; PHYSIOLOGY; WING;

ANIMALS; CARRIER PROTEINS; CELL NUCLEUS; DROSOPHILA; DROSOPHILA PROTEINS; IMMUNOHISTOCHEMISTRY; LARVA; MULTIPROTEIN COMPLEXES; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; WINGS, ANIMAL;

EID: 84930226959     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10339     Document Type: Article

References (45)

1. Wullschleger S., Loewith R. & Hall M. N. TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
2. Gough N. R. Focus issue: TOR signaling, a tale of two complexes. Sci. Signal 5, eg4 (2012).
3. Betz C. & Hall M. N. Where is mTOR and what is it doing there? J. Cell Biol. 203, 563-574 (2013).
4. Zoncu R., Efeyan A. & Sabatini D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35 (2011).
5. Aimbetov R. et al. Integrity of mTORC2 is dependent on the rictor Gly-934 site. Oncogene. 31, 2115-2120 (2012).
6. Guertin D. A. et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859-871 (2006).
7. Hietakangas V., Cohen S. M. & Re-evaluating A. K. T. regulation: role of TOR complex 2 in tissue growth. Genes. Dev. 21, 632-637 (2007).
8. Jones K. T., Greer E. R., Pearce D. & Ashrafi K. Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS biology 7, e60 (2009).
9. Wang T., Blumhagen R., Lao U., Kuo Y. & Edgar B. A. LST8 regulates cell growth via target-of-rapamycin complex 2 (TORC2). Mol. Cell Biol. 32, 2203-2213 (2012).
10. Cornu M., Albert V. & Hall M. N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53-62 (2013).
11. Laplante M., Sabatini D. M. mTOR signaling in growth control and disease. Cell 149, 274-293 (2012).
12. Pearce L. R., Komander D. & Alessi D. R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22 (2010).
13. Jacinto E. et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137 (2006).
14. Dang C. V. MYC on the path to cancer. Cell 149, 22-35 (2012).
15. Eilers M. & Eisenman R. N. Myc's broad reach. Genes. Dev. 22, 2755-2766 (2008).
16. Parisi F. et al. Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo. BMC Biol. 9, 65 (2011).
17. Gallant P. Myc function in Drosophila. Cold Spring Harb. Perspect. Med. 3, a014324 (2013).
18. Orian A. et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes. Dev. 17, 1101-1114 (2003).
19. Hulf T. et al. Whole-genome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes. Mol. Cell Biol. 25, 3401-3410 (2005).
20. Grewal S. S., Li L., Orian A., Eisenman R. N. & Edgar B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat. Cell Biol. 7, 295-302 (2005).
21. Marshall L., Rideout E. J. & Grewal S. S. Nutrient/TOR-dependent regulation of RNA polymerase III controls tissue and organismal growth in Drosophila. EMBO J. 31, 1916-1930 (2012).
22. Iritani B. M. & Eisenman R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA 96, 13180-13185 (1999).
23. Johnston L. A., Prober D. A., Edgar B. A., Eisenman R. N. & Gallant P. Drosophila myc regulates cellular growth during development. Cell 98, 779-790 (1999).
24. Conacci-Sorrell M., McFerrin L. & Eisenman R. N. An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 4, a014357 (2014).
25. Teleman A. A., Hietakangas V., Sayadian A. C. & Cohen S. M. Nutritional control of protein biosynthetic capacity by insulin via Myc in Drosophila. Cell Metab. 7, 21-32 (2008).
26. Hsu P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322 (2011).
27. Trapnell C., Pachter L. & Salzberg S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
28. Trapnell C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
29. Huang da W., Sherman B.T. & Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
30. Secombe J., Li L., Carlos L. & Eisenman R. N. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes. Dev. 21, 537-551 (2007).
31. de la Cova C., Abril M., Bellosta P., Gallant P. & Johnston L. A. Drosophila myc regulates organ size by inducing cell competition. Cell 117, 107-116 (2004).
32. Soukas A. A., Kane E. A., Carr C. E., Melo J. A. & Ruvkun G. Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes. Dev. 23, 496-511 (2009).
33. Zinzalla V., Stracka D., Oppliger W. & Hall M. N. Activation of mTORC2 by association with the ribosome. Cell 144, 757-768 (2011).
34. Li Z. & Hann S. R. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene. 32, 1988-1994 (2013).
35. Chan J. C. et al. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer. Sci. Signal 4, ra56 (2011).
36. Pourdehnad M. et al. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc. Natl. Acad. Sci. USA 110, 11988-11993 (2013).
37. Babcock J. T. et al. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response. J. Biol. Chem. 288, 15687-15698 (2013).
38. Tan J. et al. B55beta-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 18, 459-471 (2010).
39. Amcheslavsky A., Ito N., Jiang J. & Ip Y. T. Tuberous sclerosis complex and Myc coordinate the growth and division of Drosophila intestinal stem cells. J. Cell Biol. 193, 695-710 (2011).
40. Guertin D. A. et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15, 148-159 (2009).
41. Fu Z. & Tindall D. J. FOXOs, cancer and regulation of apoptosis. Oncogene. 27, 2312-2319 (2008).
42. Oh W. J. & Jacinto E. mTOR complex 2 signaling and functions. Cell Cycle 10, 2305-2316 (2011).
43. Jensen K. S. et al. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function. EMBO J. 30, 4554-4570 (2011).
44. Ferber E. C. et al. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ 19, 968-979 (2012).
45. Masui K. et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 18, 726-739 (2013).